Skip to contentX
Xenetic Biosciences, Inc.
X
XBIOXenetic Biosciences, Inc. Q2 2019 · 10-Q
Revenue$0.00$0.00no prior Q2 2018 on file Net Income-$1.38M-$1.38MN/M vs Q2 2018 EPS Diluted-$1.56-$1.56N/M vs Q2 2018 Operating Income-$1,378,298N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
derived
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end